Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate time to progression in women with hormone responsive
advanced breast cancer treated with a combination of exemestane and fulvestrant.
Phase:
Phase 2
Details
Lead Sponsor:
Ewa Mrozek Ohio State University Comprehensive Cancer Center